• Recent
  • Class
  • Inventors
  • Assignees
  • Top Lists
  • Pricing
  • Account
Patents-Review.com
  1. Home
  2. Inventor
  3. R
  4. Roh…
  5. Rohrer Daniel
🔗 Permalink
Inventor profile of:

Daniel Rohrer

City:

Los Gatos, California

Country:

United States

Published Applications:

5

Last publication date:

2026-01-22

Recent patent applications by Rohrer Daniel

Daniel Rohrer from Los Gatos, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-22
US20260022395A1
Chemistry; metallurgy

HUMAN IMMUNOGLOBULIN COMMON LIGHT CHAIN TRANSGENE CONSTRUCTS AND USES THEREOF

#2 | 2024-08-08
US20240263190A1
Chemistry; metallurgy

HUMAN IMMUNOGLOBULIN BINARY LIGHT CHAIN TRANSGENE CONSTRUCTS AND USES THEREOF

#3 | 2024-08-08
US20240260553A1
Human necessities

CHIMERIC TRANSGENIC IMMUNOGLOBULIN MICE WITH AN ALTERED HEAVY CHAIN LOCUS AND METHODS OF MAKING AND USING SAME

#4 | 2024-07-18
US20240239919A1
Chemistry; metallurgy

HUMAN IMMUNOGLOBULIN HEAVY CHAIN LONG CDR3 TRANSGENE CONSTRUCTS AND USES THEREOF

#5 | 2011-07-07
US20110166330A1
Chemistry; metallurgy

GPCR crystalization method using an antibody

InventorID:

3547385 ⎘

  1. Home
  2. Inventor
  3. R
  4. Roh…
  5. Rohrer Daniel

Some parts © 2022-2026 Patents-Review.com

Browse & Discovery
  • Home
  • Patent Classification
  • Inventor Index
  • Assignee Index
  • Interesting Applications
Search & Tools
  • Basic Search
  • Advanced Search
  • Patent Alerts
  • Top Lists
  • Statistics
Information & Resources
  • About US Patent System
  • Terms & Privacy
  • Pricing
  • Contact
Quick Access
  • Latest Applications
  • Top Inventors 2026
  • Top Assignees 2026
  • Featured Patents
Disclaimer: This website is intended for informational purposes only, and its content is based on public patent records. Please note that some sections of this website have been created or processed using machine learning models. We provide content in good faith but make no guarantees regarding accuracy or completeness. By using this site, you accept any risks and waive claims against us for errors or omissions.